VR
Virbac S.A.
VRBCF · OTC
$383.25 +0.00% (+$0.00)
Market Cap 2.86B €
P/E Ratio 18.99x
Div. Yield 0.43%
ROE 13.56%
Bulios Fair Price
$371.63
3.0% downside
Current Price
$383.25
Undervalued Fair Value Overvalued
According to Bulios Fair Price, VRBCF is currently trading close to its fair value. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Moderate
6/9Valuation
57 /100
Fair P/FCF 27.72x
P/S 1.96x
P/B 2.55x
Growth
67 /100
Growing Rev. growth 6.38%
FCF growth 31.55%
Book val. growth 10.25%
Profitability
61 /100
Moderate Net margin 10.30%
Op. margin 14.89%
FCF margin 7.06%
Quality
62 /100
Average ROE 13.56%
ROA 7.88%
Asset turnover 0.77x
Debt
96 /100
Low Current ratio 1.53x
Int. coverage 25.29x
Net debt/EBITDA 0.62x
Stability
100 /100
Stable Rev. volatility 4.99%
EPS volatility 11.10%
Profitable years 6
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about VRBCF
Online
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Paul Martingell
Employees
6,442
Headquarters
Carros
Upcoming events
23 MAR
Earnings
Upcoming earnings report